What's breaking now, across thousands of outlets.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
(MedPage Today) -- Christa Pike was scheduled to be executed. But after two injections, she kept breathing. She made snoring sounds, she talked, she said her arm was hurting.
'I can't go through World FTD Awareness Week without talking about Bruce. He is the driving force behind my advocacy,' Emma Heming Willis wrote.
Plus news about Regeneron. Summit Therapeutics to test cancer drug with Datroway: The biotech agreed to partner with AstraZeneca and Daiichi Sankyo on a clinical trial collaboration, testing its…
While the transition to motherhood can be challenging for anyone, barriers such as inadequate health literacy, unreliable transportation, difficulty navigating a complex health care system, limited access to child care or insecure housing can be the tipping point between a new mom accessing needed care or going without it.
Researchers at the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center have discovered how to control and stop the amplification of MYC—one of the most commonly altered cancer genes linked to aggressive tumor growth and treatment resistance.
One in 100 adolescents and young adults in the United States has an opioid use disorder (OUD) and, with the rise of fentanyl in the drug supply, overdoses in this age group have risen sharply since 2019.
